Autism-Focused Seaside Therapeutics Raises $30 Million
Seaside Therapeutics LLC, a Cambridge, Mass.-based drug startup focused on autism and Fragile X Syndrome, has raised $30 million from an undisclosed family investment firm.
17 September 2009•3 mins read
